Fehr M - Search Results

1

Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.

Chau C, Cathomas R, Wheater M, Klingbiel D, Fehr M, Bennett J, Markham H, Lee C, Crabb SJ, Geldart T. Chau C, et al. Among authors: fehr m. Ann Oncol. 2015 Sep;26(9):1865-1870. doi: 10.1093/annonc/mdv254. Epub 2015 Jun 2. Ann Oncol. 2015. PMID: 26037797 Free article.

2

Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.

Cathomas R, Klingbiel D, Geldart TR, Mead GM, Ellis S, Wheater M, Simmonds P, Nagaraj N, von Moos R, Fehr M. Cathomas R, et al. Among authors: fehr m. Ann Oncol. 2014 Aug;25(8):1591-7. doi: 10.1093/annonc/mdu129. Epub 2014 Mar 25. Ann Oncol. 2014. PMID: 24669017 Free article.

3

Measurement or estimation of glomerular filtration rate in seminoma patients: quite another cup of tea.

Fehr M, Geldart T, Klingbiel D, Cathomas R. Fehr M, et al. Eur J Cancer. 2014 Aug;50(12):2176-7. doi: 10.1016/j.ejca.2014.04.028. Epub 2014 Jun 7. Eur J Cancer. 2014. PMID: 24915777 No abstract available.

4

Spontaneous pneumothorax during chemotherapy: a case report.

Fehr M, von Moos R, Furrer M, Cathomas R. Fehr M, et al. Onkologie. 2010;33(10):527-30. doi: 10.1159/000319743. Epub 2010 Sep 20. Onkologie. 2010. PMID: 20926900 Review.

5

Carboplatin dose based on actual renal function: no excess of acute haematotoxicity in adjuvant treatment in seminoma stage I.

Fehr M, Maranta AF, Reichegger H, Gillessen S, Cathomas R. Fehr M, et al. ESMO Open. 2018 Mar 8;3(3):e000320. doi: 10.1136/esmoopen-2018-000320. eCollection 2018. ESMO Open. 2018. PMID: 29531843 Free PMC article.

6

Metastatic angiosarcoma arising from the right atrium: unusual presentation and excellent response to treatment in a young patient.

Fehr M, Kuhn M, Mayer K, Padberg B, Ulmer U, Cathomas R. Fehr M, et al. J Thorac Oncol. 2010 Aug;5(8):1301-2. doi: 10.1097/JTO.0b013e3181dd1c78. J Thorac Oncol. 2010. PMID: 20661090 Free article. No abstract available.

7

Multidisciplinary care in patients with prostate cancer: room for improvement.

Strebel RT, Sulser T, Schmid HP, Gillessen S, Fehr M, Huber U, Pless M, Morant R, Winterhalder R, Cathomas R. Strebel RT, et al. Among authors: fehr m. Support Care Cancer. 2013 Aug;21(8):2327-33. doi: 10.1007/s00520-013-1791-x. Epub 2013 Mar 26. Support Care Cancer. 2013. PMID: 23529667

8

Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06).

Rochlitz C, Ruhstaller T, Lerch S, Spirig C, Huober J, Suter T, Bühlmann M, Fehr M, Schönenberger A, von Moos R, Winterhalder R, Rauch D, Müller A, Mannhart-Harms M, Herrmann R, Cliffe B, Mayer M, Zaman K; Swiss Group for Clinical Cancer Research (SAKK). Rochlitz C, et al. Among authors: fehr m. Ann Oncol. 2011 Jan;22(1):80-85. doi: 10.1093/annonc/mdq319. Epub 2010 Jul 1. Ann Oncol. 2011. PMID: 20595448 Free article. Clinical Trial.

9

Primary manifestation of small lymphocytic lymphoma in the prostate.

Fehr M, Templeton A, Cogliatti S, Aebersold F, Egli F, Gillessen S, Cathomas R. Fehr M, et al. Onkologie. 2009 Oct;32(10):586-8. doi: 10.1159/000232584. Epub 2009 Sep 11. Onkologie. 2009. PMID: 19816076 Review.

10

The influence of bevacizumab on platelet function.

Fehr M, Catschegn S, Reinhart WH, Madon J, Asmis L, Cathomas R, von Moos R. Fehr M, et al. Swiss Med Wkly. 2011 Jul 30;141:w13243. doi: 10.4414/smw.2011.13243. eCollection 2011. Swiss Med Wkly. 2011. PMID: 21805405 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

317 results

Search Page